JAVIER
PUENTE VÁZQUEZ
Profesor asociado
Hospital de Sabadell
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital de Sabadell (5)
2019
2016
-
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study
BMC Cancer, Vol. 16, Núm. 1
-
Randomized placebo controlled phase II trial (MAJA): Efficacy results of maintenance vinflunine after cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC). SOGUG 2011-02
Annals of Oncology, Vol. 27, pp. vi277
-
SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016)
Clinical and Translational Oncology, Vol. 18, Núm. 12, pp. 1197-1205